21
Nov 2025
At the cellular level, the mechanics of how muscle tissue repair occurs gets complicated. There are significant differences between, say, tearing a muscle in a sports injury versus muscle tissue wasting away from diseases like muscular dystrophy.
21
Nov 2025
Targeting and treating diseases first requires being able to find specific cells-which is challenging because they travel within the body and can "hide."
21
Nov 2025
Medical reports written in technical terminology can pose challenges for patients. A team at the Technical University of Munich (TUM) has investigated how artificial intelligence can make CT findings easier to understand.
21
Nov 2025
Aston University's Dr Jonathan Cox and New Zealand Mānuka honey company Comvita have announced a significant milestone in their three-year research collaboration, with the filing of a new patent for a formulation to fight bacterial infections.
21
Nov 2025
The liver plays a central role in storing and supplying energy to the body. In type 2 diabetes and metabolic dysfunction-associated steatotic liver disease (MASLD, commonly referred to as fatty liver disease), mitochondria-the cell's power plants-cannot switch efficiently between fuel sources.
21
Nov 2025
Major depressive disorder (MDD) is characterized by a lowered mood and loss of interest, contributing not only to difficulties in academic and professional life but also as a major cause of suicide in South Korea.
21
Nov 2025
University of Virginia School of Medicine and Naval Medical Research Command (NMRC) researchers will use a federal Department of Defense grant to better identify, prevent and treat brain injuries for military personnel caused by repeated blast exposures.
21
Nov 2025
A team of researchers at IOCB Prague headed by Dr. Tomáš Slanina has developed a new method for labeling molecules with fluorescent dyes that surpasses existing approaches in both precision and stability.
21
Nov 2025
The roots of addiction risk may lie in how young brains function long before substance use begins, according to a new study from Weill Cornell Medicine.
21
Nov 2025
Alzheimer's disease (AD), a progressive neurodegenerative disorder, is one of the leading causes of dementia worldwide, and currently has no definitive cure. Although antibody-based therapies that target amyloid β (Aβ) have recently been developed, their clinical effectiveness remains limited.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more
